2026-01-04 - Analysis Report
Here's a comprehensive analysis of Intuitive Surgical (ISRG) based on the provided data, broken down into sections for clarity:

**0) Overview**

*   **Simple Numbers:** The report presents raw data points, including cumulative returns, moving averages, RSI, PPO, news headlines, analyst ratings, earnings data, and financial metrics.
*   **Simple Analysis:**  The analysis interprets the raw data, identifying trends, potential risks, and opportunities related to ISRG.

**1) Return Rate Comparison**

*   **Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets robotic surgical systems.
*   **Cumulative Return of ISRG:** 78.60%
*   **Cumulative Return of S&P 500 (VOO):** 91.00%
*   **Divergence:**  Divergence (max: 73.3, min: -47.8, current: -12.4, relative divergence: 29.2)
*   **Analysis:** ISRG has underperformed the S&P 500 over the measured period. The divergence is currently at -12.4%, meaning ISRG's return is 12.4% lower than VOO's. The relative divergence of 29.2 suggests the current divergence is relatively low compared to its historical range.

**Alpha, Beta Analysis**

|            | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2016-2018  | 49.0%   | 29.0%   | 45.0%   | 1.2   | 57.2   |
| 2017-2019  | 40.0%   | 29.0%   | 23.0%   | 1.4   | 70.6   |
| 2018-2020  | -8.0%   | 29.0%   | -29.0%  | 1.2   | 97.8   |
| 2019-2021  | 26.0%   | 21.1%   | -17.0%  | 1.2   | 128.8  |
| 2020-2022  | -18.0%  | 48.9%   | -16.0%  | 1.2   | 95.1   |
| 2021-2023  | -12.0%  | 48.9%   | -13.0%  | 1.4   | 120.9  |
| 2022-2024  | 35.0%   | 38.0%   | 16.0%   | 1.3   | 187.1  |
| 2023-2025  | 60.0%   | 28.0%   | -2.0%   | 1.2   | 203.0  |

*   **CAGR:** The Compound Annual Growth Rate shows varying performance, with strong growth in some periods (2016-2018, 2023-2025) and declines in others (2018-2020, 2020-2022, 2021-2023).
*   **MDD:** The Maximum Drawdown indicates the largest peak-to-trough decline, with periods around 30-49% indicating significant volatility.
*   **Alpha:** The alpha is highly variable, sometimes significantly positive (2016-2018) and often negative, suggesting ISRG underperforms expectations given its risk (Beta).
*   **Beta:** The beta values around 1.2-1.4 suggest that ISRG's price tends to move more than the market (S&P 500).
*   **Cap(B):** The market capitalization has generally increased over time, peaking at $203 Billion for the 2023-2025 period.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** 561.98
*   **Previous Close:** 566.36
*   **Change:** -0.77
*   **5-day SMA:** 570.836
*   **20-day SMA:** 565.4205
*   **60-day SMA:** 540.1655

*   **Analysis:** The stock price closed slightly lower than its previous close. The 5-day SMA is above the 20-day SMA, which is above the 60-day SMA.  This could signal a potential short-term downtrend reversing, but the data suggests short-term price is falling more than long-term.

**3) RSI, PPO, and Expected Return**

*   **MRI:** 0.8 (Medium Investment Recommended)
*   **RSI:** 60.21
*   **PPO:** -0.2423
*   **Hybrid Signal:** Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** -2.3 (short-term decline)
*   **Expected Return (%):** 4.3%

*   **Analysis:** The MRI suggests a medium investment recommendation.  The RSI indicates a slightly overbought condition.  The negative PPO suggests the price is slightly below its moving average. The Hybrid Signal recommends a 90% cash investment. The short-term divergence change indicates a recent decline. The expected return of 4.3% is an estimate of potential future outperformance compared to the S&P 500 over a long-term investment horizon.

**4) Recent News & Significant Events**

*   **Key Headlines:**
    *   Intuitive Surgical stock falls (ts2.tech)
    *   Stock hits key support (Trefis)
    *   Analysts raise price targets (Yahoo Finance)
    *   Opinions on 2025 growth guidance update (Quiver Quantitative)
    *   Shares acquired by SteelPeak Wealth LLC (MarketBeat)
    *   Technical indicators in focus (Meyka)

*   **Analysis:** The news is mixed. Some articles highlight price declines and technical indicators, while others focus on analyst upgrades and potential buying opportunities at support levels. This suggests uncertainty and potentially conflicting views on the stock's near-term prospects.

**4-2) Analyst Opinions**

*   **Consensus:** Neutral rating.
*   **Target Price:** Average target price of 599.60, with a high of 700.00 and a low of 378.00.
*   **Recent Rating Changes:** No specific recent rating changes provided.

*   **Analysis:**  The neutral consensus and wide range in target prices suggest analysts have differing opinions on ISRG's value and future performance. The average target price is above the current price, indicating potential upside according to analysts.

**5) Recent Earnings Analysis**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2025-10-22 | 1.98 | 2.51 B$     |
| 2025-07-23 | 1.84 | 2.44 B$     |
| 2025-04-23 | 1.95 | 2.25 B$     |
| 2024-10-18 | 1.59 | 2.04 B$     |
| 2025-10-22 | 1.59 | 2.04 B$     |

*   **Analysis:**  Both EPS and Revenue have shown generally positive growth in recent quarters. The most recent quarter (2025-10-22) shows strong EPS and revenue figures. The repeated 2025-10-22 and 2024-10-18 is probably a data error.

**6) Financial Information**

*   **Revenue and Profitability**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $2.51B  | 66.36%        |
| 2025-06-30   | $2.44B  | 66.31%        |
| 2025-03-31   | $2.25B  | 64.69%        |
| 2024-12-31   | $2.41B  | 68.04%        |
| 2024-09-30   | $2.04B  | 67.41%        |

*   **Analysis:** Revenue has been increasing generally. Profit margins are consistently high, indicating strong pricing power and operational efficiency.

*   **Capital and Profitability**

| Quarter      | Equity   | ROE    |
|--------------|----------|--------|
| 2025-09-30   | $16.93B  | 4.16%  |
| 2025-06-30   | $17.85B  | 3.69%  |
| 2025-03-31   | $17.11B  | 4.08%  |
| 2024-12-31   | $16.43B  | 4.17%  |
| 2024-09-30   | $15.58B  | 3.63%  |

*   **Analysis:** Equity has generally increased. ROE (Return on Equity) has fluctuated, but is in a relatively consistent range, suggesting a stable return on shareholder investment.

**7) Comprehensive Analysis (Summary)**

*   **Performance:** ISRG has underperformed the S&P 500 recently. However, past performance shows periods of strong growth and periods of decline.
*   **Volatility:**  The stock exhibits relatively high volatility (beta > 1). The maximum drawdown has been significant, especially recently, suggesting large price swings.
*   **Technicals:** The recent stock price is slightly below its 5-day and 20-day SMA. RSI is just slightly below the overbought conditions.
*   **Market Sentiment:**  News headlines are mixed, with some articles highlighting potential downside and others suggesting buying opportunities. Analyst ratings are neutral, with a wide range of target prices.
*   **Financials:** Revenue and profitability are strong, with high profit margins and growing revenue. ROE is stable.
*   **Investment Recommendation:** Based on the MRI of 0.8, the data suggests a *medium* investment recommendation. While the stock has faced recent headwinds and underperformed the S&P 500, the company's strong financial performance and potential for future growth (as indicated by analyst target prices) could make it a worthwhile investment for investors with a long-term perspective and tolerance for volatility. However, potential investors should carefully consider the risks and perform their own due diligence before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.